Literature DB >> 30124471

Mitochondrial dysfunction in pathophysiology of heart failure.

Bo Zhou, Rong Tian.   

Abstract

Mitochondrial dysfunction has been implicated in the development of heart failure. Oxidative metabolism in mitochondria is the main energy source of the heart, and the inability to generate and transfer energy has long been considered the primary mechanism linking mitochondrial dysfunction and contractile failure. However, the role of mitochondria in heart failure is now increasingly recognized to be beyond that of a failed power plant. In this Review, we summarize recent evidence demonstrating vicious cycles of pathophysiological mechanisms during the pathological remodeling of the heart that drive mitochondrial contributions from being compensatory to being a suicide mission. These mechanisms include bottlenecks of metabolic flux, redox imbalance, protein modification, ROS-induced ROS generation, impaired mitochondrial Ca2+ homeostasis, and inflammation. The interpretation of these findings will lead us to novel avenues for disease mechanisms and therapy.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30124471      PMCID: PMC6118589          DOI: 10.1172/JCI120849

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  158 in total

1.  Identification of a molecular component of the mitochondrial acetyltransferase programme: a novel role for GCN5L1.

Authors:  Iain Scott; Bradley R Webster; Jian H Li; Michael N Sack
Journal:  Biochem J       Date:  2012-05-01       Impact factor: 3.857

2.  Long-term effects of increased glucose entry on mouse hearts during normal aging and ischemic stress.

Authors:  Ivan Luptak; Jie Yan; Lei Cui; Mohit Jain; Ronglih Liao; Rong Tian
Journal:  Circulation       Date:  2007-08-06       Impact factor: 29.690

3.  Calcium ions and the regulation of NAD+-linked isocitrate dehydrogenase from the mitochondria of rat heart and other tissues.

Authors:  R M Denton; D A Richards; J G Chin
Journal:  Biochem J       Date:  1978-12-15       Impact factor: 3.857

4.  Neurohormonal Blockade in Heart Failure.

Authors:  Thomas G von Lueder; Dipak Kotecha; Dan Atar; Ingrid Hopper
Journal:  Card Fail Rev       Date:  2017-04

5.  A role for mitochondria in NLRP3 inflammasome activation.

Authors:  Rongbin Zhou; Amir S Yazdi; Philippe Menu; Jürg Tschopp
Journal:  Nature       Date:  2010-12-01       Impact factor: 49.962

6.  Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor.

Authors:  Tadahiro Shimazu; Matthew D Hirschey; John Newman; Wenjuan He; Kotaro Shirakawa; Natacha Le Moan; Carrie A Grueter; Hyungwook Lim; Laura R Saunders; Robert D Stevens; Christopher B Newgard; Robert V Farese; Rafael de Cabo; Scott Ulrich; Katerina Akassoglou; Eric Verdin
Journal:  Science       Date:  2012-12-06       Impact factor: 47.728

7.  Triggering the succinate receptor GPR91 on dendritic cells enhances immunity.

Authors:  Tina Rubic; Günther Lametschwandtner; Sandra Jost; Sonja Hinteregger; Julia Kund; Nicole Carballido-Perrig; Christoph Schwärzler; Tobias Junt; Hans Voshol; Josef G Meingassner; Xiaohong Mao; Gudrun Werner; Antal Rot; José M Carballido
Journal:  Nat Immunol       Date:  2008-09-28       Impact factor: 25.606

8.  Acetylation contributes to hypertrophy-caused maturational delay of cardiac energy metabolism.

Authors:  Arata Fukushima; Liyan Zhang; Alda Huqi; Victoria H Lam; Sonia Rawat; Tariq Altamimi; Cory S Wagg; Khushmol K Dhaliwal; Lisa K Hornberger; Paul F Kantor; Ivan M Rebeyka; Gary D Lopaschuk
Journal:  JCI Insight       Date:  2018-05-17

9.  Local control of mitochondrial membrane potential, permeability transition pore and reactive oxygen species by calcium and calmodulin in rat ventricular myocytes.

Authors:  Keiichi Odagiri; Hideki Katoh; Hirotaka Kawashima; Takamitsu Tanaka; Hayato Ohtani; Masao Saotome; Tsuyoshi Urushida; Hiroshi Satoh; Hideharu Hayashi
Journal:  J Mol Cell Cardiol       Date:  2009-01-20       Impact factor: 5.000

10.  Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes.

Authors:  D B Zorov; C R Filburn; L O Klotz; J L Zweier; S J Sollott
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

View more
  173 in total

1.  Exploring mechanisms of increased cardiovascular disease risk with antipsychotic medications: Risperidone alters the cardiac proteomic signature in mice.

Authors:  Megan Beauchemin; Ramaz Geguchadze; Anyonya R Guntur; Kathleen Nevola; Phuong T Le; Deborah Barlow; Megan Rue; Calvin P H Vary; Christine W Lary; Katherine J Motyl; Karen L Houseknecht
Journal:  Pharmacol Res       Date:  2019-12-23       Impact factor: 7.658

2.  DNA methylation reprograms cardiac metabolic gene expression in end-stage human heart failure.

Authors:  Mark E Pepin; Stavros Drakos; Chae-Myeong Ha; Martin Tristani-Firouzi; Craig H Selzman; James C Fang; Adam R Wende; Omar Wever-Pinzon
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-07-12       Impact factor: 4.733

3.  Tead1 is essential for mitochondrial function in cardiomyocytes.

Authors:  Ruya Liu; Rajaganapathi Jagannathan; Lingfei Sun; Feng Li; Ping Yang; Jeongkyung Lee; Vinny Negi; Eliana M Perez-Garcia; Sruti Shiva; Vijay K Yechoor; Mousumi Moulik
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-06-05       Impact factor: 4.733

4.  Both gain and loss of Nampt function promote pressure overload-induced heart failure.

Authors:  Jaemin Byun; Shin-Ichi Oka; Nobushige Imai; Chun-Yang Huang; Guersom Ralda; Peiyong Zhai; Yoshiyuki Ikeda; Shohei Ikeda; Junichi Sadoshima
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-07-26       Impact factor: 4.733

Review 5.  Irisin: linking metabolism with heart failure.

Authors:  Jiamin Li; Susu Xie; Lei Guo; Jun Jiang; Han Chen
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

6.  Boosting NAD level suppresses inflammatory activation of PBMCs in heart failure.

Authors:  Bo Zhou; Dennis Ding-Hwa Wang; Yanhua Qiu; Sophia Airhart; Yaxin Liu; April Stempien-Otero; Kevin D O'Brien; Rong Tian
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

Review 7.  Macrophage activation as an archetype of mitochondrial repurposing.

Authors:  Anthony E Jones; Ajit S Divakaruni
Journal:  Mol Aspects Med       Date:  2020-01-16

Review 8.  Metabolism, Epigenetics, and Causal Inference in Heart Failure.

Authors:  Todd H Kimball; Thomas M Vondriska
Journal:  Trends Endocrinol Metab       Date:  2019-12-19       Impact factor: 12.015

Review 9.  Blood-based bioenergetics: An emerging translational and clinical tool.

Authors:  Andrea Braganza; Gowtham K Annarapu; Sruti Shiva
Journal:  Mol Aspects Med       Date:  2019-12-18

Review 10.  Unlocking the Secrets of Mitochondria in the Cardiovascular System: Path to a Cure in Heart Failure—A Report from the 2018 National Heart, Lung, and Blood Institute Workshop

Authors:  Rong Tian; Wilson S. Colucci; Zoltan Arany; Markus M. Bachschmid; Scott W. Ballinger; Sihem Boudina; James E. Bruce; David W. Busija; Sergey Dikalov; Gerald W. Dorn; Zorina S. Galis; Roberta A. Gottlieb; Daniel P. Kelly; Richard N. Kitsis; Mark J. Kohr; Daniel Levy; E. Douglas Lewandowski; Joseph M. McClung; Daria Mochly-Rosen; Kevin D. O'Brien; Brian O'Rourke; Joon-Young Park; Peipei Ping; Michael N. Sack; Shey-Shing Sheu; Yang Shi; Sruti Shiva; Douglas C. Wallace; Robert G. Weiss; Hilary J. Vernon; Renee Wong; Lisa Schwartz Longacre
Journal:  Circulation       Date:  2019-10-01       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.